High-dose idarubicin and busulphan as conditioning regimen to autologous stem cell transplantation in acute myeloid leukemia

被引：0
|
作者：
Ferrara, F
Palmieri, S
Annunziata, M
Copia, C
Pollio, F
Mele, G
机构：
来源：
BONE MARROW TRANSPLANTATION | 2002年 / 29卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P401
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [1] High-dose idarubicin and busulphan as conditioning regimen to autologous stem cell transplantation in acute myeloid leukaemia
    Ferrara, F
    Palmieri, S
    De Simone, M
    D'Amico, MR
    Fasanaro, A
    Viola, A
    Annunziata, M
    Mele, G
    BONE MARROW TRANSPLANTATION, 2004, 33 : S233 - S233
  • [2] CONTINUOUS INFUSION HIGH DOSE IDARUBICIN AND INTRAVENOUS BUSULPHAN AS CONDITIONING REGIMEN TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Ferrara, F.
    Palmieri, S.
    Copia, C.
    Criscuolo, C.
    Izzo, T.
    Pedata, M.
    Pollio, F.
    Viola, A.
    Falco, C.
    Mele, G.
    HAEMATOLOGICA, 2008, 93 : S133 - S133
  • [3] Autologous Stem Cell Transplantation with Moderate Dose of Idarubicin and Busulphan as Conditioning Regimen in Acute Myelogenous Leukemia
    Mashhadi, M. A.
    Ramzi, M.
    Alimoghaddam, K.
    IRANIAN RED CRESCENT MEDICAL JOURNAL, 2008, 10 (03) : 202 - 207
  • [4] High-dose idarubicin and busulphan as conditioning to autologous stem cell transplantation in adult patients with acute myeloid leukaemia
    Ferrara, F
    Palmieri, S
    De Simone, M
    Sagristani, M
    Viola, A
    Pocali, B
    Fasanaro, A
    Mele, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (02) : 234 - 241
  • [5] HIGH DOSE IDARUBICIN AS CONTINUOUS INFUSION AND INTRAVENOUS BUSULPHAN AS CONDITIONING REGIMEN TO AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Ferrara, F.
    Palmieri, S.
    Copia, C.
    Criscuolo, C.
    Pedata, M.
    Izzo, T.
    Pollio, E.
    Viola, A.
    Mele, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 566 - 566
  • [6] Busulphan and idarubicin as conditioning regimen for autologous stem cell transplantation in patients with acute myeloid leukemia in first or subsequent remission
    Ferrara, F
    Annunziata, M
    Copia, C
    Palmieri, S
    Pollio, F
    Schiavone, EM
    Mele, G
    BONE MARROW TRANSPLANTATION, 2001, 27 : S88 - S88
  • [7] High-dose idarubicin and busulphan as conditioning regimen to autologous stem cell transplantation in elderly patients (age >60 years) with acute myeloid leukaemia
    Ferrara, F.
    Palmieri, S.
    Copia, C.
    Tambaro, F. P.
    Pedata, M.
    Izzo, T.
    Pollio, F.
    Falco, C.
    Viola, A.
    Mele, G.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S106 - S106
  • [8] Continuous High-Dose Idarubicin and Busulfan As Conditioning Regimen for Chinese Patients with Acute Myeloid Leukemia Undergoing Autologous Stem Cell Transplantation
    Ming, Hong
    Qian, Sixuan
    Peng, Liu
    Wu Hanxin
    Qiu Hongxia
    Hua, Lu
    Zhang Sujiang
    Wei, Xu
    BLOOD, 2012, 120 (21)
  • [9] Four years survival in autologous stem cell transplantation with moderate dose of idarubicin and busulphan as conditioning regimen in acute myelogenous leukemia
    Mashhadi, M. A., Sr.
    Ramzi, M.
    Alimoghaddam, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Continuous infusion idarubicin and intravenous busulphan as conditioning regimen to autologous stem cell transplantation for patients with acute myeloid leukaemia
    Ferrara, Felicetto
    Mele, Giuseppina
    Palmieri, Salvatore
    Pedata, Mariangela
    Copia, Carolina
    Riccardi, Cira
    Izzo, Tiziana
    Criscuolo, Clelia
    Musto, Pellegrino
    HEMATOLOGICAL ONCOLOGY, 2009, 27 (04) : 198 - 202
12345